Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension

Summary

The purpose of this study is to compare the antihypertensive effect of azilsartan medoxomil versus placebo in Korean adults with essential hypertension.

Timeline

Start

2014-07

Primary completion

2016-01

Completion

2016-02

Publications

• Juhasz A, Wu J, Hisada M, Tsukada T, Jeong MH. Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension. Clin Hypertens. 2018 Feb 7;24:2. doi: 10.1186/s40885-018-0086-4. eCollection 2018.

Drugs

Indications